Successful treatment with “re-switching” of regorafenib and cetuximab for mCRC patient with liver metastases

Category Primary study
JournalAnnals of Oncology
Year 2015
This article has no abstract
Epistemonikos ID: 51db4cd3c39dc778655592b9718e6622b761ef51
First added on: Feb 07, 2025